Filing Details

Accession Number:
0001209191-23-059683
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-26 16:29:30
Reporting Period:
2023-12-22
Accepted Time:
2023-12-26 16:29:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601485 Elicio Therapeutics Inc. ELTX Pharmaceutical Preparations (2834) 113430072
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1977769 Gkcc, Llc 501 Silverside Road, Suite 87Ava
Wilmington DE 19809
No No Yes No
1979324 Yekaterina Chudnovsky C/O Elicio Therapeutics, Inc.
451 D Street, 5Th Floor, Suite 501
Boston MA 02210
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-22 1,213,000 $5.81 1,915,639 No 4 P Indirect Held by GKCC, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by GKCC, LLC
Footnotes
  1. Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.